![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PARIS, France, June 4, 2024 – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.24 | 1.88976377953 | 12.7 | 13.3 | 11.74 | 26389 | 12.40412023 | DE |
4 | 0.24 | 1.88976377953 | 12.7 | 13.58 | 11.74 | 19456 | 12.59872896 | DE |
12 | -0.4 | -2.99850074963 | 13.34 | 15.42 | 11.74 | 24043 | 13.52821072 | DE |
26 | 3.14 | 32.0408163265 | 9.8 | 15.42 | 9.35 | 29548 | 12.42281457 | DE |
52 | -2.96 | -18.6163522013 | 15.9 | 19.18 | 7.89 | 35846 | 11.93141382 | DE |
156 | -16.56 | -56.1355932203 | 29.5 | 36.7 | 5.6 | 31828 | 13.97856638 | DE |
260 | 4.56 | 54.415274463 | 8.38 | 36.7 | 5.6 | 32050 | 16.86984358 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions